1 | LLY | Eli Lilly and Company | 22.52% |
2 | JNJ | Johnson & Johnson | 22.43% |
3 | RPRX | Royalty Pharma plc | 4.75% |
4 | VTRS | Viatris Inc. | 4.65% |
5 | PFE | Pfizer Inc. | 4.54% |
6 | MRK | Merck & Co., Inc. | 4.50% |
7 | ZTS | Zoetis Inc. | 4.29% |
8 | BMY | Bristol-Myers Squibb Company | 4.26% |
9 | ELAN | Elanco Animal Health Incorporated | 3.55% |
10 | CORT | Corcept Therapeutics Incorporated | 3.51% |
11 | JAZZ | Jazz Pharmaceuticals plc | 3.31% |
12 | AXSM | Axsome Therapeutics, Inc. | 2.12% |
13 | PBH | Prestige Consumer Healthcare Inc. | 2.01% |
14 | PRGO | Perrigo Company plc | 1.83% |
15 | OGN | Organon & Co. | 1.30% |
16 | LGND | Ligand Pharmaceuticals Incorporated | 1.12% |
17 | SUPN | Supernus Pharmaceuticals, Inc. | 0.87% |
18 | TARS | Tarsus Pharmaceuticals, Inc. | 0.77% |
19 | HRMY | Harmony Biosciences Holdings, Inc. | 0.61% |
20 | AMRX | Amneal Pharmaceuticals, Inc. | 0.61% |
21 | OCUL | Ocular Therapeutix, Inc. | 0.61% |
22 | INVA | Innoviva, Inc. | 0.56% |
23 | ANIP | ANI Pharmaceuticals, Inc. | 0.56% |
24 | PCRX | Pacira BioSciences, Inc. | 0.55% |
25 | HROW | Harrow, Inc. | 0.50% |
View IHE holdings |